Discrete event simulation applied to pediatric phase I oncology designs.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D017321:Clinical Trials, Phase I as Topic; D003198:Computer Simulation; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D020714:Maximum Tolerated Dose; D008495:Medical Oncology / Q000458:organization & administration; D015233:Models, Statistical; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018579:Patient Selection; D010372:Pediatrics / Q000458:organization & administration; D012107:Research Design; D018570:Risk Assessment; D012680:Sensitivity and Specificity